These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 12761498

  • 1. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
    Budunova IV, Kowalczyk D, Pérez P, Yao YJ, Jorcano JL, Slaga TJ.
    Oncogene; 2003 May 22; 22(21):3279-87. PubMed ID: 12761498
    [Abstract] [Full Text] [Related]

  • 2. The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells.
    Chebotaev D, Yemelyanov A, Zhu L, Lavker RM, Budunova I.
    Oncogene; 2007 May 10; 26(21):3060-8. PubMed ID: 17146443
    [Abstract] [Full Text] [Related]

  • 3. The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin.
    Chebotaev D, Yemelyanov A, Budunova I.
    Mol Carcinog; 2007 Aug 10; 46(8):732-40. PubMed ID: 17538956
    [Abstract] [Full Text] [Related]

  • 4. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
    Budunova IV, Carbajal S, Kang H, Viaje A, Slaga TJ.
    Mol Carcinog; 1997 Mar 10; 18(3):177-85. PubMed ID: 9115588
    [Abstract] [Full Text] [Related]

  • 5. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA, Wang XJ, Donehower LA, Roop DR.
    Cancer Res; 1996 Oct 01; 56(19):4413-23. PubMed ID: 8813135
    [Abstract] [Full Text] [Related]

  • 6. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
    Lee S, Chari NS, Kim HW, Wang X, Roop DR, Cho SH, DiGiovanni J, McDonnell TJ.
    Mol Carcinog; 2007 Dec 01; 46(12):949-57. PubMed ID: 17538944
    [Abstract] [Full Text] [Related]

  • 7. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG.
    Oncogene; 2001 Aug 30; 20(38):5341-9. PubMed ID: 11536046
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM, Bolon I, Nichols A, Wohlwend A, Vassalli JD.
    Cancer Res; 2001 Feb 01; 61(3):970-6. PubMed ID: 11221892
    [Abstract] [Full Text] [Related]

  • 9. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K, Bol D, Carbajal S, Beltrán L, Moats S, Chan K, Jorcano J, DiGiovanni J.
    Oncogene; 2000 Aug 31; 19(37):4243-54. PubMed ID: 10980598
    [Abstract] [Full Text] [Related]

  • 10. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
    Pierce AM, Fisher SM, Conti CJ, Johnson DG.
    Oncogene; 1998 Mar 12; 16(10):1267-76. PubMed ID: 9546428
    [Abstract] [Full Text] [Related]

  • 11. Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptor.
    Pérez P, Page A, Bravo A, Del Río M, Giménez-Conti I, Budunova I, Slaga TJ, Jorcano JL.
    FASEB J; 2001 Sep 12; 15(11):2030-2. PubMed ID: 11511512
    [Abstract] [Full Text] [Related]

  • 12. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras.
    Dlugosz AA, Hansen L, Cheng C, Alexander N, Denning MF, Threadgill DW, Magnuson T, Coffey RJ, Yuspa SH.
    Cancer Res; 1997 Aug 01; 57(15):3180-8. PubMed ID: 9242447
    [Abstract] [Full Text] [Related]

  • 13. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation.
    Rodríguez-Villanueva J, Greenhalgh D, Wang XJ, Bundman D, Cho S, Delehedde M, Roop D, McDonnell TJ.
    Oncogene; 1998 Feb 19; 16(7):853-63. PubMed ID: 9484776
    [Abstract] [Full Text] [Related]

  • 14. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
    Chan KS, Sano S, Kataoka K, Abel E, Carbajal S, Beltran L, Clifford J, Peavey M, Shen J, Digiovanni J.
    Oncogene; 2008 Feb 14; 27(8):1087-94. PubMed ID: 17700521
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Rel/Nuclear Factor-kappaB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development.
    van Hogerlinden M, Auer G, Toftgård R.
    Oncogene; 2002 Jul 25; 21(32):4969-77. PubMed ID: 12118375
    [Abstract] [Full Text] [Related]

  • 16. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
    Rossiter H, Beissert S, Mayer C, Schön MP, Wienrich BG, Tschachler E, Kupper TS.
    Cancer Res; 2001 May 01; 61(9):3619-26. PubMed ID: 11325830
    [Abstract] [Full Text] [Related]

  • 17. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM, Florell SR, Hanks AN, Alexander A, Diedrich MJ, Altieri DC, Grossman D.
    Cancer Res; 2003 Feb 01; 63(3):567-72. PubMed ID: 12566297
    [Abstract] [Full Text] [Related]

  • 18. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
    Mustacich D, Wagner A, Williams R, Bair W, Barbercheck L, Stratton SP, Bhattacharyya AK, Powis G.
    Carcinogenesis; 2004 Oct 01; 25(10):1983-9. PubMed ID: 15166090
    [Abstract] [Full Text] [Related]

  • 19. Disruption of eyelid and cornea development by targeted overexpression of the glucocorticoid receptor.
    Cascallana JL, Bravo A, Page A, Budunova I, Slaga TJ, Jorcano JL, Pérez P.
    Int J Dev Biol; 2003 Feb 01; 47(1):59-64. PubMed ID: 12653252
    [Abstract] [Full Text] [Related]

  • 20. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ, Liefer KM, Greenhalgh DA, Roop DR.
    Mol Carcinog; 1999 Dec 01; 26(4):305-11. PubMed ID: 10569807
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.